Prosecution Insights
Last updated: August 15, 2026

Kindeva Drug Delivery L.P.

8 pending office actions • 5 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready

Portfolio Summary

8
Total Pending OAs
7
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (50%)
4
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (38%)
Double-patenting + other1 (12%)
Multi-statute (no §101)4 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
12% of docket
2
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAGHIGHATIAN, MINA 2 45.8% +39.7%
CHANG, THOMAS ZHU 1 52.6% +75.0%
CHI, AMANDA LYNN 1
MOON, MATTHEW RYAN 1 57.6% +60.8%
SONG, JIANFENG 1 56.2% +33.1%
MOK, ANDREW JUN-WAI 1 52.1% +67.2%
GHALI, ISIS A D 1 27.9% +41.5%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17921774 ADHESIVE ARTICLE AND METHOD OF MAKING SAME MOK, ANDREW JUN-WAI 49d overdue
18606272 FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION HAGHIGHATIAN, MINA 5d overdue
17612132 Removable Film-Forming Gel Compositions Featuring Adhesion Promoters GHALI, ISIS A D 50d
18694108 INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS CHANG, THOMAS ZHU
18689555 METERED DOSE INHALERS AND SOLUTION COMPOSITIONS MOON, MATTHEW RYAN

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17921774 ADHESIVE ARTICLE AND METHOD OF MAKING SAME MOK, ANDREW JUN-WAI 49d overdue
18606272 FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION HAGHIGHATIAN, MINA 5d overdue
17612132 Removable Film-Forming Gel Compositions Featuring Adhesion Promoters GHALI, ISIS A D 50d
18694108 INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS CHANG, THOMAS ZHU
18689555 METERED DOSE INHALERS AND SOLUTION COMPOSITIONS MOON, MATTHEW RYAN
18014444 DRUG DELIVERY DEVICE INCLUDING PATCH SEGMENTS SONG, JIANFENG
17620325 AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE HAGHIGHATIAN, MINA

Top Art Units

Art UnitApps
1616 2
1627 1
1613 1
3786 1
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18694108 INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS CHANG, THOMAS ZHU §102§103§112 Non-Final OA Pending Mar 21, 2024
18606272 FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION HAGHIGHATIAN, MINA 1616 §103§112 Non-Final OA 5d overdue Pending Mar 15, 2024
18689579 PROPELLANTS FOR ANTICHOLINERGIC AGENTS IN PRESSURIZED METERED DOSE INHALERS CHI, AMANDA LYNN 1627 §103 Non-Final OA Pending Mar 06, 2024
18689555 METERED DOSE INHALERS AND SOLUTION COMPOSITIONS MOON, MATTHEW RYAN §103§112 Non-Final OA Pending Mar 06, 2024
18014444 DRUG DELIVERY DEVICE INCLUDING PATCH SEGMENTS SONG, JIANFENG 1613 §103 Non-Final OA Pending Jan 04, 2023
17921774 ADHESIVE ARTICLE AND METHOD OF MAKING SAME MOK, ANDREW JUN-WAI 3786 §102§103§112 Non-Final OA 49d overdue Pending Oct 27, 2022
17620325 AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE HAGHIGHATIAN, MINA 1616 §103§112DP Non-Final OA Pending Dec 17, 2021
17612132 Removable Film-Forming Gel Compositions Featuring Adhesion Promoters GHALI, ISIS A D 1611 §103Other Non-Final OA 50d Pending Nov 17, 2021

Managing Kindeva Drug Delivery L.P.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month